Intrinsic Value of S&P & Nasdaq Contact Us

America Great Health AAGH OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

America Great Health (AAGH) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 22/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $294,670, +31%/yr average growth. Net income is $1M (loss), growing at -561.5%/yr. Net profit margin is -414.2% (negative). Gross margin is 57.6% (+31.4 pp trend).

Balance sheet: total debt is $2M with negative equity of -$5M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.06 (tight liquidity). Debt-to-assets is 767.8%. Total assets: $323,478.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

AAGH SharesGrow Score Overview

39/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.018
Volume500
Avg Volume (30D)6.71M
Market Cap$2.12M
Beta (1Y)6.40
Share Statistics
EPS (TTM)0.00
Shares Outstanding$21.12B
IPO Date2012-09-25
Employees5
CEOMike Qingkun Wang
Financial Highlights & Ratios
Revenue (TTM)$294.67K
Gross Profit$169.75K
EBITDA$-767.85K
Net Income$-1.22M
Operating Income$-782.7K
Total Cash$54.94K
Total Debt$2.48M
Net Debt$2.43M
Total Assets$323.48K
Price / Earnings (P/E)-1
Price / Sales (P/S)7.18
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS02365T1016

Price Chart

AAGH
America Great Health  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message